Jetrea

Chemical Nameocriplasmin
Dosage FormInjection (intravitreal; 2.5mg/mL)
Drug ClassEnzymes
SystemOcular
CompanyThromboGenics Inc.
Approval Year2012

Indication

  • For the treatment of symptomatic vitreomacular adhesion.
Last updated on 5/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Jetrea (ocriplasmin) Prescribing Information2012ThromboGenics Inc., Iselin, NJ